Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies

导出原文传递

翻译打印收藏纠错

作者： Hardan, Antonio Y. ^[1] ; Hendren, Robert L. ^[2] ; Aman, Michael G. ^[3] ; Robb, Adelaide ^[4] ; Melmed, Raun D. ^[5] ; Andersen, Kristen A. ^[6] ; Luchini, Rachel ^[7] ; Rahman, Rezwanur ; Ali, Sanjida ; Jia, X. Daniel ; Mallick, Madhuja ; Lateiner, Jordan E. ; Palmer, Robert H. ; Graham, Stephen M.

作者单位： Stanford Univ, 401 Quarry Rd, Stanford, CA 94305 USA ^[1] Ohio State Univ, Columbus, OH 43210 USA ^[2] Univ Calif San Francisco, San Francisco, CA 94143 USA ^[3] Childrens Natl Med Ctr, Washington, DC 20010 USA ^[4] Allergan Plc, Madison, NJ USA ^[5] Prescott Med Commun Grp, Chicago, IL USA ^[6] Southwest Autism Res & Resource Ctr, Phoenix, AZ USA ^[7]

关键词 Asperger's disorder autism spectrum disorders clinical trial medication memantine pervasive developmental disorder-not otherwise specified randomized withdrawal school-age children Social Responsiveness Scale

发布时间 2020-02-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交